Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Raises Price Target to $54
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong maintains an Equal-Weight rating on TransMedics Gr (NASDAQ:TMDX) and raises the price target from $50 to $54.
November 07, 2023 | 2:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on TransMedics Gr and raises the price target from $50 to $54, which could potentially lead to a positive market reaction.
The raised price target by Morgan Stanley indicates a positive outlook for TransMedics Gr. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100